COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,244 Articles (22,733 medRxiv, 8,511 bioRxiv)

Most recent first Previous |  Page 2775: Articles 27741-27750  | Next

A single dose SARS-CoV-2 simulating particle vaccine induces potent neutralizing activities
Cai, Y., Yin, D., Ling, S., Tian, X., Li, Y., Xu, Z., Jiang, H., Zhang, X., Wang, X., Shi, Y., Zhang, Y., Da, L., Tao, S.-c., Wang, Q., Xu, J., Ying, T., Hong, J.
10.1101/2020.05.14.093054 — Posted: 2020-05-15 Discussion: Onsite | Offsite
Favipiravir strikes the SARS-CoV-2 at its Achilles heel, the RNA polymerase
Shannon, A., Selisko, B., Le, T.-T.-N., Huchting, J., Touret, F., Piorkowski, G., Fattorini, V., Ferron, F., Decroly, E., Meier, C., Coutard, B., Peersen, O., Canard, B.
10.1101/2020.05.15.098731 — Posted: 2020-05-15
Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike protein
Walker, L. M., Wec, A. Z., Wrap, D., Herbert, A. S., Maurer, D. P., Haslwanter, D., Sakharkar, M., Jangra, R. K., Dieterle, M. E., Lilov, A., Huang, D., Tse, L. V., Johnson, N. V., Hsieh, C.-L., Wang, N., Nett, J. H., Champney, E., Burnina, I., Brown, M., Lin, S., Sinclair, M., Johnson, C., Pudi, S., Bortz, R., Wirchnianski, A. S., Laudermilch, E., Florez, C., Fels, J. M., O'Brien, C. M., Graham, B. S., Nemazee, D., Burton, D. R., Baric, R. S., Voss, J. E., Chandran, K., Dye, J. M., McLellan, J. S.
10.1101/2020.05.15.096511 — Posted: 2020-05-15
Transcriptional profiling reveals TRPM5-expressing cells involved in viral infection in the olfactory epithelium
Baxter, B. D., Larson, E. D., Feinstein, P., Polese, A. G., Bubak, A. N., Niemeyer, C. S., Merle, L., Shepherd, D., Ramakrishnan, V. R., Nagel, M. A., Restrepo, D.
10.1101/2020.05.14.096016 — Posted: 2020-05-15
Sequence Characterization and Molecular Modeling of Clinically Relevant Variants of the SARS-CoV-2 Main Protease
Cross, T. J., Takahashi, G. R., Diessner, E. M., Crosby, M. G., Farahmand, V., Zhuang, S., Butts, C. T., Martin, R. W.
10.1101/2020.05.15.097493 — Posted: 2020-05-15
Distribution of ACE2, CD147, cyclophilins, CD26 and other SARS-CoV-2 associated molecules in human tissues and immune cells in health and disease
Radzikowska, U., Ding, M., Tan, G., Zhakparov, D., Peng, Y., Wawrzyniak, P., Wang, M., Li, S., Morita, H., Altunbulakli, C., Reiger, M., Neumann, A. U., Lunjani, N., Traidl-Hoffmann, C., Nadeau, K., O'Mahony, L., Akdis, C. A., Sokolowska, M.
10.1101/2020.05.14.090332 — Posted: 2020-05-15
Pre-existing and de novo humoral immunity to SARS-CoV-2 in humans
Ng, K., Faulkner, N., Cornish, G., Rosa, A., Earl, C., Wrobel, A., Benton, D., Roustan, C., Bolland, W., Thompson, R., Agua-Doce, A., Hobson, P., Heaney, J., Rickman, H., Paraskevopoulou, S., Houlihan, C. F., Thomson, K., Sanchez, E., Shin, G. Y., Spyer, M. J., Walker, P. A., Kjaer, S., Riddell, A., Beale, R., Swanton, C., Gandhi, S., Stockinger, B., Gamblin, S., McCoy, L. E., Cherepanov, P., Nastouli, E., Kassiotis, G.
10.1101/2020.05.14.095414 — Posted: 2020-05-15 Discussion: Onsite | Offsite
Recommendations for sample pooling on the Cepheid GeneXpert(R) system using the Cepheid Xpert(R) Xpress SARS-CoV-2 assay
Becker, M. G., Taylor, T., Kiazyk, S., Cabiles, D. R., Meyers, A. F. A., Sandstrom, P. A.
10.1101/2020.05.14.097287 — Posted: 2020-05-15
IgA MAb blocks SARS-CoV-2 Spike-ACE2 interaction providing mucosal immunity
Ejemel, M., Li, Q., Hou, S., Schiller, Z. A., Wallace, A. L., Amcheslavsky, A., Kurt Yilmaz, N., Toomey, J. R., Schneider, R., Close, B. J., Chen, D.-Y., Conway, H. L., Saeed, M., Cavacini, L. A., Klempner, M. S., Schiffer, C. A., Wang, Y.
10.1101/2020.05.15.096719 — Posted: 2020-05-15
Two mutations P/L and Y/C in SARS-CoV-2 helicase domain exist together and influence helicase RNA binding
Begum, F., Banerjee, A. K., Tripathi, P. P., RAY, U.
10.1101/2020.05.14.095224 — Posted: 2020-05-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).